Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients

被引:11
|
作者
Hevey, D [1 ]
McGee, HM
Fitzgerald, D
Horgan, JH
机构
[1] Beaumont Hosp, Dept Cardiol, Dublin 9, Ireland
[2] Royal Coll Surg Ireland, Dept Psychol, Hlth Serv Res Ctr, Dublin 2, Ireland
[3] Royal Coll Surg Ireland, Dept Clin Pharmacol, Dublin 2, Ireland
关键词
psychological stress; tissue plasminogen activator; plasminogen activator inhibitor-1; atherosclerosis;
D O I
10.1007/s004210000299
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Tissue plasminogen activator (tPA) promotes fibrinolysis and impaired fibrinolysis is associated with atherosclerosis and thrombosis. Plasminogen activator inhibitor-1 (PAI-1) inhibits t-PA expression. The effects of acute laboratory stressors on tPA and tPA/PAI-1 complexes were assessed in a sample of 11 cardiac patients. Participants were randomly assigned to either a stress or relaxation condition at time 1, and the alternative condition at time 2. Blood samples were taken before (pre) and after (post) each session and participants completed a battery of psychological questionnaires. Two-way repeated-measures analysis of variance revealed a statistically significant decrease in tPA (P = 0.01) and tPA-PAI-1 complexes (P = 0.04) during the mental stress condition. Anger-in had a strong relationship to decreases in tPA/PAI-1 levels in the stress condition (r = 0.68, P < 0.05). Relaxation had no significant effect on tPA and tPA/PAI-1 levels. These data suggest that decreased fibrinolysis mediates the relationship between mental stress and atherosclerosis.
引用
收藏
页码:344 / 348
页数:5
相关论文
共 50 条
  • [1] Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients
    D. Hevey
    H. M. McGee
    D. Fitzgerald
    J. H. Horgan
    [J]. European Journal of Applied Physiology, 2000, 83 : 344 - 348
  • [2] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    [J]. DIABETES, 1994, 43 : A197 - A197
  • [3] Do plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator PAI-1 complexes (tPA-PAI-1) Predict complications in type 1 diabetes (TID)?
    Bosnyak, Z
    Forrest, KYZ
    Maser, RE
    Orchard, TJ
    [J]. DIABETES, 2001, 50 : A209 - A209
  • [4] Clearance of tissue plasminogen activator (TPA) and TPA plasminogen activator inhibitor type 1 (PAI-1) complex - Relationship to elevated TPA antigen in patients with high PAI-1 activity levels
    Chandler, WL
    Alessi, MC
    Aillaud, MF
    Henderson, P
    Vague, P
    JuhanVague, I
    [J]. CIRCULATION, 1997, 96 (03) : 761 - 768
  • [5] Lovastatin modulates tissue plasminogen activator (tPA)/plasminogen activator inhibitor-1 (PAI-1) balance in rat proximal tubular cells (RPTC).
    Essig, M
    Nguyen, G
    Vrtovsnik, F
    Friedlander, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2530 - A2530
  • [6] Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
    Mennesson, Marie
    Revest, Jean-Michel
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [7] Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
    Cho, Hee Young
    Park, Han Sung
    Ahn, Eun Hee
    Ko, Eun Ju
    Park, Hyeon Woo
    Kim, Young Ran
    Kim, Ji Hyang
    Lee, Woo Sik
    Kim, Nam Keun
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [8] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    [J]. STROKE, 1996, 27 (06) : 1066 - 1071
  • [9] Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
    Johansson, L
    Jansson, JH
    Boman, K
    Nilsson, TK
    Stegmayr, B
    Hallmans, G
    [J]. STROKE, 2000, 31 (01) : 26 - 32
  • [10] TISSUE-PLASMINOGEN ACTIVATOR (TPA), PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1(PAI-1) IN DIABETIC PREGNANT-WOMEN
    BRONISZ, A
    KOTSCHY, M
    ROSC, D
    GRACZYKOWSKAKOCZOROWSKA, A
    DREWNIAK, W
    [J]. DIABETOLOGIA, 1995, 38 : A285 - A285